BILL · 2011–12 SESSION

HB 2495: Opioid analgesic drugs

Prohibiting pharmacists from substituting opioid analgesic drugs for an opioid analgesic drug incorporating a tamper resistance technology without verifying equivalence or obtaining the written, signed consent of the prescribing physician.

Summary

  • Prohibits pharmacists from substituting an opioid analgesic drug for an opioid analgesic drug incorporating tamper resistance properties, unless the drug has substantially similar tamper resistance properties or the prescribing physician provides written consent for the substitution.

From the House Bill Analysis 2012 (HB 2495), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 16, 2012
  2. Out of committeestopped here
  3. Passed House
  4. Passed Senate
  5. Governor
  6. Law
Prime sponsor
Laurie Jinkins (D-27)
Introduced
January 16, 2012 in the House
Last action
April 11, 2012
Companion bill
SB 6424
Budget
Has a fiscal note

AN ACT Relating to prohibiting pharmacists from substituting opioid analgesic drugs for an opioid analgesic drug incorporating a tamper resistance technology without verifying equivalence or obtaining the written, signed consent of the prescribing physician;

Sponsors

Prime sponsor: Laurie Jinkins (D-27)

5 co-sponsors (3 Democrats, 2 Republicans)

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. By resolution, reintroduced and retained in present status.
  2. By resolution, reintroduced and retained in present status.
  3. First reading, referred to Health Care & Wellness.

HB 2495 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page